PRF injections for mild to moderate jaw joint wear
Treatments studied
Part of Bones, joints & muscles, Mouth & dental clinical trials.
This study tests whether injecting iPRF (a therapy made from your blood growth factors) into the jaw joint can reduce symptoms from mild to moderate jaw joint degeneration. It’s being compared against standard care for people who currently are not on other jaw-joint treatments.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You’re between 18 and 80 years old
- You have mild to moderate jaw joint degeneration confirmed by exam/imaging (DC/TMD plus MRI/CT)
- You agree to join the study and follow its procedures
- You have not had any jaw-joint invasive treatment before joining
- You are not currently taking any jaw-joint treatments (conservative or invasive)
- You are not pregnant or breastfeeding and you can safely have a needle procedure
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This trial looks at whether injecting platelet-rich plasma (PRP) or platelet-rich fibrin (PRF) during TMJ surgery helps with recovery. It aims to see if these treatments improve healing after jaw joint surgery.
This trial tests whether a treatment made from your own blood (platelet-rich plasma exosomes) can help relieve long-term jaw joint pain and improve function. If you qualify, you would receive injections directly into your jaw area.
This study tests whether injections of platelet-rich plasma (a substance made from your own blood) can reduce pain in the jaw muscles. If you have had jaw muscle pain for at least 3 months, this treatment might help.
This trial tests a treatment for deep gum disease pockets using a combination of your own blood components (injectable platelet-rich fibrin) and a bone graft material. It aims to help regenerate bone lost to periodontitis.
This study compares two guided injection techniques—ultrasound and arthroscopy—to deliver platelet-rich fibrin (PRF), a regenerative treatment, into the temporomandibular joint (the jaw joint). PRF may help reduce pain and improve jaw function in patients with disc displacement who haven't improved with conservative care like splints or physical therapy.
This trial tests if platelet-rich plasma (PRP) injections into and around the knee joint can reduce pain and improve function for people with moderate knee osteoarthritis who haven't gotten relief from other treatments.
Hear when a new Temporomandibular Disorder trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.